It's official. Abbott has joined a select group of companies that have increased their quarterly dividends 50 years in a row.
This strong history comes during an unprecedented time as the U.S. approaches nearly two years of pandemic. Yet Abbott's diverse business model continues to be highly resilient, as seen in the company's year-to-date growth across all four major businesses.
Abbott has increased its 2022 quarterly dividend by 4.4%, boosting payouts to 47 cents per share. This follows a 25% dividend increase in 2021, and maintains the company's place in the prestigious S&P 500 Dividend Aristocrats Index of companies that have raised dividend payouts for at least 25 years.
Fueling this increase is consistently strong performance across Abbott, with year-to-date organic growth up 29.6% compared to the same period in 2020.
Half a century of dividend increases also demonstrates Abbott's longstanding commitment to delivering sustainable growth that fuels innovation as well as shareholder returns. The company has a track record of building long-term value, including during times of uncertainty. Abbott has returned more than $31 billion to shareholders through dividends during the last 15 years, thanks to its diverse business model as well as strong management and execution.
This latest milestone is one of many in Abbott's 130-plus years of building a healthier world. It's a reflection of Abbott employees' dedication and the company's relentless focus on creating life-changing technologies that help people live their fullest possible lives.
Learn more about Abbott's latest quarterly dividend increase.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
FOLLOW ABBOTT